Medical Devices industry M&A deals total $2.6bn globally in June 2022

Total Medical devices industry M&A deals worth $2.6bn were announced globally in June 2022, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.

The value marked an increase of 164% over the previous month of $1bn and a drop of 63.6% when compared with the last 12-month average, which stood at $7.26bn.

Comparing M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $1.14bn. At the country level, the Germany topped the list in terms of deal value at $1.09bn.

In terms of volumes, Europe emerged as the top region for Medical devices industry M&A deals globally, followed by North America and then Asia-Pacific.

The top country in terms of M&A deals activity in June 2022 was the US with 17 deals, followed by the UK with five and Germany with three.

In 2022, as of June, Medical devices M&A deals worth $12.46bn were announced globally, marking an increase of 67.3% year on year.

Medical devices industry M&A deals in June 2022: Top deals

The top five M&A deals accounted for 90.9% of the overall value during June 2022.

The combined value of the top five Medical devices M&A deals stood at $2.4bn, against the overall value of $2.6bn recorded for the month.

The top five Medical devices industry M&A deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $534.27m acquisition of Instituto Hermes Pardini by Fleury

3) Evolent Health $462m acquisition deal with Implantable Provider Group

4) The $230m acquisition of 64% stake in M.I.Tech by Boston Scientific

5) Guardant Health $177.8m acquisition deal with Guardant Health AMEA